MedTrace Logo

AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer

NCT05002556 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2026-04-30

No results posted yet for this study

Summary

The AFU has set itself the task of setting up a register of medical practices in order to define possible improvements in the therapeutic management and follow-up of NMIBC. In order to obtain representative data, all urologists who are members of the AFU may be invited to include their patients.

Conditions

  • Non-Muscle-Invasive Bladder Cancer

Sponsors & Collaborators

  • Association Francaise d'Urologie

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-21
Primary Completion
2034-02-28
Completion
2035-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05002556 on ClinicalTrials.gov